Drug
Scopolamine clinical trials
Also written Hyoscine.
- studies test it
- 38
- open now
- 2
- in phase 3
- 6
- first study started
- 2003
Keep track of what changes. Save the Scopolamine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Development codes
Other names
Combined with it in one product
Studies by the year they started
38 studies that test it; most in 2016 (5)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 9
- Phase 2
- 10
- Phase 3
- 6
- Phase 4
- 8
- No phase
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 28
Repurposed Therapeutics, Inc. (5) · Medical Corps, Israel Defense Force (2) · National Institute of Mental Health (NIMH) (2) · Massachusetts General Hospital (2) · Dartmouth-Hitchcock Medical Center (1) · Dr. Brian Hallahan (1) · Stony Brook University (1) · Rutgers, The State University of New Jersey (1)
Often tested with
Tested in the same studies.
Propofol (3) · Ketamine (3) · Meclizine (2) · Aprepitant (2) · Dexmedetomidine (2) · Fentanyl (2) · Sevoflurane (2) · Desflurane (2)
Studies
Open first, then newest update. How each study uses Scopolamine is read from its arms, and is right about nine times in ten.
Testing it · 38
- Pharmacological Modulation of Brain Oscillations in Memory ProcessingRecruitingEarly Phase 1University of Texas Southwestern Medical CenterNCT05594017Written as Scopolamine (0.4mg)
- Representation of Spatiotemporal Information in Human Episodic Memory and NavigationEnrolling by invitationEarly Phase 1University of ArizonaNCT07423923Written as Scopolamine
- Motion Sickness Medications and Vestibular Time ConstantCompletedPhase 4Medical Corps, Israel Defense ForceNCT03270839Written as Kwells
- Nebulizer Delivery of Intranasal ScopolamineCompletedPhase 1Dartmouth-Hitchcock Medical CenterNCT04999449Written as Scopolamine
- PET and MRI Imaging With Scopolamine at the Muscarinic M1 ReceptorWithdrawnPhase 1Yale UniversityNCT06014385Written as Scopolamine
- Scopolamine in Bipolar DepressionCompletedPhase 2Dr. Brian HallahanNCT04211961Written as Scopolamine
- Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve GastrectomyCompletedPhase 4Stony Brook UniversityNCT03435003Written as scopolamine transdermal
- Prevention and Treatment of Nausea Associated With Motion Sickness in Senior SubjectsCompletedPhase 3Repurposed Therapeutics, Inc.NCT03988530Written as Scopolamine
- Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean SectionCompletedPhase 4Rutgers, The State University of New JerseyNCT02960113Written as scopolamine patch
- Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging StudiesTerminatedPhase 2National Institute of Mental Health (NIMH)NCT00055575Written as Scopolamine Nasal Spray
- The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALSStatus unknownPhase 2Ruijin HospitalNCT04391361Written as Scopolamine, atropine, edaravone and dexmedetomidine
- Scopolamine in Healthy VolunteersStatus unknownPhase 1Repurposed Therapeutics, Inc.NCT03874130Written as Scopolamine
- Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion SicknessStatus unknownPhase 3Repurposed Therapeutics, Inc.NCT04272255Written as scopolamine HBr
- The Prevention and Treatment of Nausea Associated With Motion SicknessCompletedPhase 3Repurposed Therapeutics, Inc.NCT03986905Written as Scopolamine Nasal Gel
- Generalization of Extinction LearningCompletedPhase 1University of California, Los AngelesNCT01900301Written as Scopolamine
- The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major DepressionCompletedPhase 4The Taub GroupNCT03386448Written as Scopolamine and naltrexone
- Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean-Going VesselsStatus unknownPhase 3Naval Aeromedical Research Unit, DaytonNCT03920644Written as Scopolamine Transdermal Patch [Transderm Scop]
- Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) ProphylaxisCompletedNot applicableVanderbilt UniversityNCT02625181Written as Scopolamine
- Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDDCompletedPhase 4Capital Medical UniversityNCT03131050Written as Scopolamine
- Scopolamine Challenge StudyCompletedPhase 1PfizerNCT01213355Written as Scopolamine
See all 38 studies that test Scopolamine →
Given in every arm · 5 — Scopolamine is usual care beside what is tested
- Multimodal Analgesia Effect on Post Surgical PatientCompletedPhase 4University of California, DavisNCT04240626Written as Scopolamine patch
- The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic ExpressionCompletedEarly Phase 1Daniela MogaNCT02849639Written as Scopolamine patch
- TAK-071 Scopolamine-Induced Cognitive Impairment StudyTerminatedPhase 1TakedaNCT02918266Written as Scopolamine
- Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and VomitingCompletedNot applicableDrexel UniversityNCT00717054Written as Scopolamine
- Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRICompletedNot applicableHebrew SeniorLifeNCT01379001Written as Scopolamine
As the comparator · 5 — what is tested is compared with Scopolamine
- Evaluation of the Efficacy of the Injection of Botulinum Toxin A vs Scopolamine Patches in the Treatment of Drooling in Children With Cerebral PalsyTerminatedPhase 3Hospices Civils de LyonNCT03616067Written as Scopoderm® patches arm
- Efficacy and Safety of Escócia Association in the Treatment of Acute PainWithdrawnPhase 2EMSNCT04666701Written as Scopolamine
- Lumbar Spine Manipulation Versus Pharmacological Therapy in Young Women With Primary DysmenorrheaCompletedNot applicableUniversity of AlcalaNCT04866355Written as Hyoscine and Ibuprofen
- DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion SicknessTerminatedPhase 2/3Repurposed Therapeutics, Inc.NCT04219982Written as Transderm Scop®
- Effect of Buscopan on Gastrointestinal Imaging Quality With Probe-based Confocal Laser EndomicroscopyStatus unknownNot applicableXijing Hospital of Digestive DiseasesNCT02725398Written as Scopolamine
Codes
What other systems call Scopolamine · ClinicalTrials.gg INT008184
- MeSH (NLM) D012601ScopolamineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) DL48G20X8XSCOPOLAMINEConfirmed FDA, NLM, Wikidata
- RxNorm 9601Confirmed FDA, Wikidata
- Wikidata Q337188L-scopolamineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47712ScopolamineOne source FDA
- DrugBank DB00747One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D012601 | Scopolamine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | DL48G20X8X | SCOPOLAMINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 9601 | — | Confirmed FDA, Wikidata |
| Wikidata | Q337188 | L-scopolamine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47712 | Scopolamine | One source FDA |
| DrugBank | DB00747 | — | One source Wikidata |
Also registered as scopolamine hydrobromide (UNII 451IFR0GXB · RxNorm 9603).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.